Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00233272 · ClinicalTrials.gov registry record

Baltimore Longitudinal Study of Aging

A clinical trial of Aging, sponsored by National Institute on Aging (NIA).

Recruiting
Registry status
10,000
Enrollment target
1
Study location

NCT00233272: Recruiting study of Aging, sponsored by National Institute on Aging (NIA).

NCT00233272 is a study of Aging that is actively recruiting participants, run by National Institute on Aging (NIA). The registered enrollment target is 10,000 participants, above the 2,157-participant average among 262 other Aging trials with a reported enrollment target (364% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00233272, a study of Aging, is actively recruiting participants, sponsored by National Institute on Aging (NIA).

RECRUITING
Registry status
10,000 participants
Enrollment target
1
Study location

Study Summary

Background: \- The Baltimore Longitudinal Study of Aging (BLSA) is a clinical research program on human aging that began in 1958. Volunteers of different ages join the study when they are healthy, and have follow-up visits for life. Visits last for multiple days. Participants are evaluated for many physical elements as well as for brain function. Physical tests are given. Information on mood, personality, and social aspects of life is also collected. This program has contributed more than any other research project to our understanding of aging. Objectives: \- To characterize the many aspects of the aging process and learn how people can successfully adapt to aging. Eligibility: \- Healthy individuals at least 20 years old. Design: * Participants will receive a booklet and video describing the tests they will take. * During a 3-day visit at the study hospital, participants will take the following tests: * Urine will be collected for 24 hours. Blood samples will be taken. A small piece of muscle tissue may be collected by a needle. * A medical questionnaire and a physical exam will be given. * Participants hearts will be tested, including with blood pressure tests and electronic monitors. They will breathe into a tube to test their lungs. * Participants will perform several exercises, including treadmill walking. * Vision, hearing, and taste will be tested. * Bone and joint X-rays may be taken. * Imaging tests will be given, such as an MRI. * Participants will answer questions to test their mental abilities. * Participants will return for follow-up visits every few years for life. The tests listed above will be given at every visit.

Primary Outcome

Characterization of the aging process

Conditions Studied

Study Locations (1)

Maryland

  • National Institute of Aging, Clinical Research Unit - Baltimore

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2014-02-03
National Institute on Aging (NIA)

131 total trials

What NCT00233272 shows while recruiting

NCT00233272 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,157-participant average among 262 other Aging trials with a reported enrollment target (364% higher).

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 0 interventions.

NCT00233272 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00233272 about?

NCT00233272 is a clinical study titled "Baltimore Longitudinal Study of Aging". Background: \- The Baltimore Longitudinal Study of Aging (BLSA) is a clinical research program on human aging that began in 1958. Volunteers of different ages join the study when they are healthy, and have follow-up visits for life. Visits last for multiple days. Participants are evaluated for many...

What is the current status of trial NCT00233272?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2014-02-03.

What conditions does trial NCT00233272 study?

This clinical trial studies the following conditions: Aging.

Who is sponsoring clinical trial NCT00233272?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00233272 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00233272's enrollment target sits among peer trials

10,000 2nd of 262 higher than 260 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00160771 · 10,000 participants

    Biomechanics/Motion Analysis Laboratory Data Bank

  • NCT00896935 · 10,000 participants

    Arizona Cancer Center Biospecimen Repository

  • NCT00898235 · 10,000 participants

    Collection of Samples and Clinical Data From Patients With Amyloid Diseases

  • NCT00992303 · 10,000 participants

    Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00233272, the US trial registry maintained by the National Library of Medicine. NCT00233272 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.